BioMarin Pharmaceutical - M&A Summary and Business Overview

Life ScienceCompany

BioMarin Pharmaceutical M&A Summary

BioMarin Pharmaceutical has acquired 2 companies.

BioMarin Pharmaceutical’s largest acquisition to date was in 2014, when it acquired Prosensa for $680M. BioMarin Pharmaceutical has acquired in 1 US state, and 2 countries. The Company’s most targeted sectors include healthcare services (50%) and life science (50%).

BioMarin Pharmaceutical Business Overview

Where is BioMarin Pharmaceutical headquartered?

BioMarin Pharmaceutical is headquartered in San Rafael, California.

What is BioMarin Pharmaceutical’s revenue?

BioMarin Pharmaceutical disclosed revenue of 2,419M USD for 2023 and 2,096M USD for 2022.

How many employees does BioMarin Pharmaceutical have?

BioMarin Pharmaceutical has 3,401 employees.

What sector is BioMarin Pharmaceutical in?

BioMarin Pharmaceutical is a life science company.

When was BioMarin Pharmaceutical founded?

BioMarin Pharmaceutical was founded in 1996.

M&A Summary

  • M&A Total Activity2
    • M&A Buy Activity2
  • Total Sectors Invested 2
  • Total Countries Invested 2

BioMarin Pharmaceutical

BioMarin Pharmaceutical, Inc.

770 Lindaro Street,
San Rafael, California 94901
United States,
(415) 506-6700
www.biomarin.com

BioMarin Pharmaceutical is a biotechnology company that develops and commercializes therapies for patients with serious and life-threatening rare and ultra-rare genetic diseases. BioMarin Pharmaceutical was founded in 1996 and is based in San Rafael, California.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.0/yr) # 2 - - - - - 2
vol $690M $690M
Sell (0.0/yr) # - - - - - - 0
  2

Most Recent M&A

Company Date Value Type
Prosensa 2014-11-24 680M USD Add-on Acquisition
Leiden, Netherlands · www.prosensa.eu
Zacharon Pharmaceuticals, Inc. 2013-01-07 10M USD Add-on Acquisition
San Diego, California
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Healthcare Services 1 (50%) 10M (1%) - -
Life Science 1 (50%) 680M (99%) - -
Total 2 $690M - -

By Geo

State/Country Buy Value Sell Value
Netherlands 1 680M - -
United States 1 10M - -
  California 1 10M - -
Domestic 1 (50%) 10M (1%) - -
Cross-border 1 (50%) 680M (99%) - -
Total 2 $690M - -

Deal Values

buy # Total
$100M to $1B 1 $680M
< $100M 1 $10M
TOTAL $690M
Largest Prosensa
$680M (2014-11-24)

 Subscribe to unlock this and 208,718
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 204K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.